GRAIL, Inc. Common Stock (GRAL)

Price$64.40

Value ScoreD

Growth ScoreA

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)-32.24%

Price vs S&P 500 (4W)27.62%

VGM Score60.57

Market Capitalization$3.08B

All Metrics

Book Value / Share (Quarterly)$60.79

P/TBV (Annual)4.59x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)38.37%

Cash Flow / Share (Quarterly)$-7.11

Price vs S&P 500 (YTD)-27.19%

Gross Margin (TTM)49.28%

Net Profit Margin (TTM)-253.22%

EPS (TTM)$-10.37

10-Day Avg Trading Volume0.72M

EPS Excl Extra (TTM)$-10.37

EPS (Annual)$-11.11

ROI (Annual)-15.84%

Gross Margin (Annual)48.46%

Net Profit Margin (5Y Avg)-4344.87%

Cash / Share (Quarterly)$20.01

Revenue Growth QoQ (YoY)28.11%

ROA (Last FY)-13.97%

Revenue Growth TTM (YoY)19.44%

EBITD / Share (TTM)$-10.71

ROE (5Y Avg)-53.29%

Operating Margin (TTM)-348.66%

Cash Flow / Share (Annual)$-7.44

P/B Ratio1.23x

P/B Ratio (Quarterly)0.85x

Net Income / Employee (Annual)$-448,700

EV / Revenue (TTM)19.26x

ROA (TTM)-14.34%

EPS Incl Extra (Annual)$-11.11

Current Ratio (Annual)11.97x

Quick Ratio (Quarterly)11.52x

3-Month Avg Trading Volume1.09M

52-Week Price Return74.40%

Revenue / Employee (TTM)$171,600

Tangible BV / Share (Quarterly)$16.65

P/S Ratio (Annual)20.90x

Asset Turnover (Annual)0.05x

52-Week High$118.84

Operating Margin (5Y Avg)-4442.08%

EPS Excl Extra (Annual)$-11.11

CapEx CAGR (5Y)-22.88%

26-Week Price Return-16.31%

Quick Ratio (Annual)11.78x

13-Week Price Return23.37%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)11.74x

Enterprise Value$3.01B

Asset Turnover (TTM)0.06x

Revenue / Employee (Annual)$161,700

Pretax Margin (Annual)-363.18%

Cash / Share (Annual)$22.43

3-Month Return Std Dev75.43%

Gross Margin (5Y Avg)37.30%

Net Income / Employee (TTM)$-434,400

ROE (Last FY)-15.84%

EPS Basic Excl Extra (Annual)$-11.11

Receivables Turnover (TTM)7.87x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-10.37

Receivables Turnover (Annual)7.62x

ROI (TTM)-16.42%

P/S Ratio (TTM)19.70x

Pretax Margin (5Y Avg)-4431.73%

Revenue / Share (Annual)$4.00

Tangible BV / Share (Annual)$18.03

Price vs S&P 500 (52W)46.20%

Year-to-Date Return-16.25%

5-Day Price Return6.68%

EPS Normalized (Annual)$-11.11

ROA (5Y Avg)-48.30%

Net Profit Margin (Annual)-277.47%

Month-to-Date Return31.57%

EBITD / Share (Annual)$-11.65

Operating Margin (Annual)-381.98%

ROI (5Y Avg)-53.29%

EPS Basic Excl Extra (TTM)$-10.37

P/TBV (Quarterly)3.10x

P/B Ratio (Annual)1.29x

Pretax Margin (TTM)-330.27%

Book Value / Share (Annual)$63.92

Price vs S&P 500 (13W)13.63%

Beta1.83x

Revenue / Share (TTM)$3.84

ROE (TTM)-16.42%

52-Week Low$29.95

vGradeD

gGradeA

mGradeB

vgmGradeB

Show chart for

Earnings Surprise History

Q1 26-2.29est. -2.82

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.00

4.08

3.93

Industry Peers — Health Services(28)

Symbol	Value Score	Growth Score	Momentum Score	Price
GRALGRAIL, Inc. Common Stock	D	A	B	$64.40
NTRANatera, Inc. Common Stock	F	A	B	$218.81
DGXQuest Diagnostics Inc.	C	D	C	$192.20
LHLabcorp Holdings Inc.	C	D	C	$256.87
EXASExact Sciences Corp	F	B	B	$0.00
GHGuardant Health, Inc. Common Stock	F	A	A	$129.14
CELCCelcuity Inc. Common Stock	—	—	B	$122.96
CAICaris Life Sciences, Inc. Common Stock	F	F	C	$16.45
RDNTRadNet, Inc. Common Stock	D	C	D	$52.89
VCYTVeracyte, Inc.	D	A	B	$48.18
FTREFortrea Holdings Inc. Common Stock	B	F	A	$15.76

About

GRAIL Inc develops a blood-based test for multi-cancer early detection designed to identify various cancer types at earlier stages. The company provides testing services focused on enabling earlier diagnosis and intervention, operating as a single business segment dedicated to cancer detection technology.